Explore the full record of transactions filed by Broadrick Dale, Executive. Officer active across 1 company, notably BioRestorative Therapies, Inc.. Cumulatively, 14 reports have been published. Split: 14 buys · 0 sell. Total volume traded: €266k. History available since 1 March 2022. The latest transaction was filed on 17 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
2,270 shares@ US$5.550.23% mcap4.2% of flowCommon StockSEC:0001567619-22-007664:0
Ideal exit: 26 Nov 2022 (T+270)
14 of 14 declarations
About Broadrick Dale
Broadrick Dale is an executive at BioRestorative Therapies, Inc. He plays a key role in the management and direction of the company, contributing to the implementation of strategies aimed at achieving organizational goals. His experience in the biological therapies sector is an asset for the company.